...
首页> 外文期刊>Journal of Medicinal Chemistry >Synthesis and biochemical evaluation of δ~2-isoxazoline derivatives as DNA methyltransferase 1 inhibitors
【24h】

Synthesis and biochemical evaluation of δ~2-isoxazoline derivatives as DNA methyltransferase 1 inhibitors

机译:δ〜2-异恶唑啉衍生物作为DNA甲基转移酶1抑制剂的合成及生化评估

获取原文
获取原文并翻译 | 示例
           

摘要

A series of Δ~2-isoxazoline constrained analogues of procaine/procainamide (7a-k and 8a-k) were prepared and their inhibitory activity against DNA methyltransferase 1 (DNMT1) was tested. Among them, derivative 7b is far more potent in vitro (IC_(50) = 150 μM) than other non-nucleoside inhibitors and also exhibits a strong and dose-dependent antiproliferative effect against HCT116 human colon carcinoma cells. The binding mode of 7b with the enzyme was also investigated by means of a simple competition assay as well as of docking simulations conducted using the recently published crystallographic structure of human DNMT1. On the basis of the findings, we assessed that the mode of inhibition of 7b is consistent with a competition with the cofactor and propose it as a novel lead compound for the development of non-nucleoside DNMT inhibitors.
机译:制备了一系列普鲁卡因/普鲁卡因酰胺的Δ〜2-异恶唑啉约束类似物(7a-k和8a-k),并测试了它们对DNA甲基转移酶1(DNMT1)的抑制活性。其中,衍生物7b在体外(IC_(50)= 150μM)远比其他非核苷抑制剂更有效,并且还具有针对HCT116人结肠癌细胞的强剂量依赖性抗增殖作用。还通过简单的竞争试验以及使用最近公布的人DNMT1晶体结构进行的对接模拟研究了7b与酶的结合模式。根据这些发现,我们评估了7b的抑制模式与与辅因子的竞争相一致,并提出将其作为开发非核苷DNMT抑制剂的新型先导化合物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号